Voting Results along with Scrutinizer Report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rekvina Laboratories Ltd held an EGM on 10th April 2026 where all 6 resolutions were passed with 100% shareholder approval. The meeting saw participation from 2 promoter representatives and 15 public shareholders. Key resolutions include: (1) Increase in authorised share capital and alteration of Memorandum of Association; (2) Alteration of Articles of Association; (3) Approval for investments, loans, guarantees and security exceeding Section 186 limits; (4) Approval of related party transactions where promoters abstained (17,45,490 votes excluded); (5) Preferential issue of equity shares for non-cash consideration where promoters abstained; and (6) Preferential issue of equity shares for cash consideration to non-promoter category. Total shares outstanding: 60,28,000. Voting participation ranged from 33.85% to 62.81% across resolutions.
All resolutions passed unanimously indicating shareholder confidence. The preferential issues may lead to equity dilution for existing shareholders. The expanded borrowing/investment limits give management greater financial flexibility. Related party transaction approval and preferential allotments warrant monitoring for potential impact on minority shareholder interests.